Trichomoniasis (Trichomonas vaginalis) Treatment
Covered by Aetna in California

WOMEN: Metronidazole 500mg orally twice daily × 7 days — per current CDC STI Treatment Guidelines (preferred regimen for women based on multicenter RCT demonstrating ~50% reduction in retesting positive vs. single-dose in symptomatic women). MEN: Metronidazole 2g orally in a single dose — single-dose regimen is preferred for men based on trial data. Abstain from alcohol during treatment and 24 hours after metronidazole (72 hours after tinidazole).

Tinidazole 2g orally in a single dose — alternative for both men and women; superior to single-dose metronidazole in cure rate (92–100% vs. 84–98% for metronidazole); preferred over metronidazole for tinidazole-sensitive strains when single-dose compliance is a priority. Metronidazole 2g single dose for women — acceptable but lower cure rate than 7-day course; appropriate when adherence concerns are primary. For treatment failure or nitroimidazole allergy: high-dose tinidazole 2g daily × 7 days; resistance testing at CDC Trichomonas laboratory if persistent failure.

Yes — generic metronidazole 500mg tablets and tinidazole 2g are Tier 1 on the Aetna CA formulary, typically $4–$10 for a full treatment course. The 7-day metronidazole course (14 tablets) is one of the least expensive STI treatments available. EPT prescriptions for partners are inexpensive self-pay at most California pharmacies even without insurance.

CDC STI Treatment Guidelines 2021 (current through 2024) specifically updated women's trichomoniasis treatment to prefer the 7-day metronidazole course over single-dose, based on a multicenter RCT showing the multidose regimen reduces the proportion of women retesting positive at 1-month test-of-cure by approximately 50%. Women with HIV should be treated with metronidazole 500mg BID × 7 days (identical to HIV-negative recommendation). Test of cure is recommended 3 months post-treatment for all trichomoniasis patients per CDC 2021 guidelines. Retesting at 3 months detects reinfection, which is the most common reason for a repeat positive result. Trichomoniasis in pregnant women increases risk of preterm labor — OB coordination is recommended.

The CDC's current (2021, operative through 2024) trichomoniasis treatment guidelines specifically updated women's treatment to prefer the 7-day course of metronidazole 500mg twice daily over the single 2g dose, following a multicenter randomized trial showing the multidose regimen reduces persistent positive retesting by approximately 50%. Single-dose metronidazole remains an alternative for women but has lower sustained cure rates. For men, the single 2g dose remains the preferred regimen because trial data support similar efficacy in men at the single-dose level. If your doctor is prescribing 7 days of metronidazole, that is guideline-concordant and represents updated best practice.

California's EPT law allows Dr. Bhavsar to write a prescription for your partner's trichomoniasis treatment without the partner having their own visit. The EPT prescription (metronidazole or tinidazole) can be filled at any California retail pharmacy. Coverage under your partner's own Aetna CA plan depends on their specific benefits — but metronidazole 500mg tablets are so inexpensive as generic (often $4–$10 self-pay) that most patients fill EPT prescriptions out-of-pocket without involving insurance. Medi-Cal covers EPT partner doses for enrolled beneficiaries through Family PACT.

Metronidazole inhibits aldehyde dehydrogenase, the enzyme that processes acetaldehyde during alcohol metabolism. If you consume alcohol while taking metronidazole (or for 24 hours after completion), acetaldehyde accumulates and causes a disulfiram-like reaction: flushing, nausea, vomiting, headache, rapid heart rate, and sweating. The reaction can range from mild and uncomfortable to quite unpleasant. The same alcohol restriction applies to tinidazole, extended to 72 hours after the last dose. Even alcohol-containing mouthwashes and some liquid medications should be avoided during this window. This is not a drug interaction that allows any safe threshold — avoid alcohol entirely.

Yes. CDC recommends retesting all patients 3 months after trichomoniasis treatment, regardless of symptom resolution. The primary reason is reinfection from an untreated partner — which is common if EPT was not completed or was refused. Antibiotic cure rates for metronidazole 7-day course are 92–100%, so a positive retest almost always reflects reinfection rather than treatment failure. If you test positive again at 3 months, the likely cause is a partner who was not treated — re-treat yourself and aggressively re-address partner treatment.

Yes. Aetna commercial plans cover telehealth visits for Trichomoniasis (Trichomonas vaginalis) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your trichomoniasis treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your trichomoniasis treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.